Inflammation is a key contributor to cardiovascular disease (CVD), influencing both its onset and progression. High-sensitivity C-reactive protein (hsCRP) serves as a reliable biomarker for detecting systemic inflammation and assessing cardiovascular risk. Recognizing the role of inflammation helps refine risk stratification and guide preventive strategies in the general population.
In this interview, Nanette Kass Wenger MD, MACC and Prof. Dr. Florian Kahles, MD discuss "C-Reactive Protein and CV Risk in the General Population".
SUGGESTED MATERIALS:
-
Amezcua-Castillo E, González-Pacheco H, Sáenz-San Martín A, et al. C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease-Advancing toward Precision Medicine. Biomedicines. 2023;11(9):2444. Published 2023 Sep 2. doi:10.3390/biomedicines11092444
Subscribe on Apple Podcasts | Subscribe to ACCEL
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research